I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Weise, Amy
87
results:
Search for persons
X
Format
Online (87)
Mediatypes
Articles (Online) (35)
Bookchapter (Online) (1)
OpenAccess-fulltext (51)
Sorted by: Relevance
Sorted by: Year
?
1
XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody dr..:
Hamilton, Erika
;
Spira, Alexander
;
Adams, Sylvia
...
Gynecologic Oncology. 176 (2023) - p. S158 , 2023
Link:
https://doi.org/10.1016/..
?
2
Phase 1 study of fianlimab, a human lymphocyte activation g..:
Hamid, Omid
;
Lewis, Karl
;
Weise, Amy
...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s179 , 2023
Link:
https://doi.org/10.25251..
?
3
43001 Phase 1 study of fianlimab, a human lymphocyte activa..:
Hamid, Omid
;
Weise, Amy
;
Lewis, Karl D.
...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB207 , 2023
Link:
https://doi.org/10.1016/..
?
4
Safety, tolerability and efficacy of agonist anti-CD27 anti..:
Sanborn, Rachel E
;
Pishvaian, Michael J
;
Callahan, Margaret K
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 8 - p. e005147 , 2022
Link:
https://doi.org/10.1136/..
?
5
A First-in-Human Phase 1 Study of a Novel Selective Androge..:
LoRusso, Patricia
;
Hamilton, Erika
;
Ma, Cynthia
...
Clinical Breast Cancer. 22 (2022) 1 - p. 67-77 , 2022
Link:
https://doi.org/10.1016/..
?
6
Identifying treatment options for BRAFV600 wild-type metast..:
LoRusso, Patricia M.
;
Sekulic, Aleksandar
;
Sosman, Jeffrey A.
...
PLOS ONE. 16 (2021) 4 - p. e0248097 , 2021
Link:
https://doi.org/10.1371/..
?
7
First-In-Human, First-In-Class, Phase I Trial of the Fucosy..:
Do, Khanh T.
;
Chow, Laura Quan Man
;
Reckamp, Karen
...
The Oncologist. 26 (2021) 11 - p. 925-e1918 , 2021
Link:
https://doi.org/10.1002/..
?
8
Phase Ia dose escalation study of OBP-801, a cyclic depsipe..:
Heath, Elisabeth I.
;
Weise, Amy
;
Vaishampayan, Ulka
...
Investigational New Drugs. 40 (2021) 2 - p. 300-307 , 2021
Link:
https://doi.org/10.1007/..
?
9
Molecular profiling of melanoma brain metastases compared t..:
In, Gino K.
;
Poorman, Kelsey
;
Saul, Michelle
...
Oncotarget. 11 (2020) 33 - p. 3118-3128 , 2020
Link:
https://doi.org/10.18632..
?
10
A Phase 1 study of RO6870810, a novel bromodomain and extra..:
Shapiro, Geoffrey I.
;
LoRusso, Patricia
;
Dowlati, Afshin
...
British Journal of Cancer. 124 (2020) 4 - p. 744-753 , 2020
Link:
https://doi.org/10.1038/..
?
11
Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study o..:
Naing, Aung
;
Infante, Jeffrey
;
Goel, Sanjay
...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
12
Correction to: Phase I study combining the aurora kinase a ..:
Goff, Laura W.
;
Azad, Nilofer S.
;
Stein, Stacey
...
Investigational New Drugs. 36 (2018) 6 - p. 1158-1158 , 2018
Link:
https://doi.org/10.1007/..
?
13
Phase I study combining the aurora kinase a inhibitor alise..:
Goff, Laura W.
;
Azad, Nilofer S.
;
Stein, Stacey
...
Investigational New Drugs. 37 (2018) 2 - p. 315-322 , 2018
Link:
https://doi.org/10.1007/..
?
14
Triplet Combination of Endocrine Therapy with CDK 4/6 Inhib..:
Bardia, Aditya
;
Cortés, Javier
;
Modi, Shanu
...
The Breast. 36 (2017) - p. S46-S47 , 2017
Link:
https://doi.org/10.1016/..
?
15
A first-in-human phase I study to evaluate the MEK1/2 inhib..:
Rosen, Lee S.
;
LoRusso, Patricia
;
Ma, Wen Wee
...
Investigational New Drugs. 34 (2016) 5 - p. 604-613 , 2016
Link:
https://doi.org/10.1007/..
1-15